Association of serum anti-Müllerian hormone and other factors with cumulative live birth rate following IVF

Reprod Biomed Online. 2020 May;40(5):675-683. doi: 10.1016/j.rbmo.2020.01.024. Epub 2020 Feb 5.

Abstract

Research question: What are the optimal values of maternal age and body mass index (BMI), paternal age and BMI, number of oocytes retrieved, and serum AMH concentrations for cumulative live birth rate (CLBR) in IVF and embryo transfer (IVF-ET)?

Design: This retrospective cohort study included 9494 women who underwent their first IVF-ET cycle between January 2017 and July 2018. The primary outcome was the CLBR within one complete cycle. Cox regression analysis was used to test the hazard ratio, with 95% confidence intervals.

Results: CLBR was significantly lower when maternal age was over 35 (adjusted P < 0.01 for age 36-38 years, adjusted P < 0.00001 for all age groups above 38 years). CBLR increased with increasing serum AMH concentrations and number of retrieved oocytes up to peak values at 5-7 ng/ml AMH and 16-20 oocytes in all women. CLBR was significantly increased when serum AMH concentrations were 3-7 ng/ml (adjusted P < 0.001) and number of oocytes retrieved was more than five (adjusted P < 0.00001). Overweight had a negative effect on CLBR compared with normal BMI in women under 35 years of age (adjusted P = 0.037). In women aged over 35 years, paternal overweight had a negative effect on CLBR compared with normal paternal BMI (adjusted P < 0.01).

Conclusions: Maternal age had an impact on optimal serum AMH concentrations and number of oocytes retrieved. Maternal overweight negatively affected CLBR in women under 35 years of age, and paternal overweight negatively affected CLBR in women over 35 years.

Keywords: Anti-Müllerian hormone; Cumulative clinical live birth rate; IVF; Maternal age; Oocyte retrieval.

MeSH terms

  • Adult
  • Anti-Mullerian Hormone / blood*
  • Birth Rate*
  • Female
  • Fertilization in Vitro / methods*
  • Humans
  • Live Birth*
  • Maternal Age
  • Oocyte Retrieval
  • Ovulation Induction
  • Pregnancy
  • Pregnancy Rate
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Mullerian Hormone